[Multicenter study on the inhibition of hepatocarcinogenesis by interferon therapy (IHIT)].
Yoshida
Haruhiko
H
Department of Gastroenterology, University of Tokyo Graduate School of Medicine.
Omata
Masao
M
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D005355:Fibrosis / Q000453:epidemiology; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D008099:Liver / Q000473:pathology; D008103:Liver Cirrhosis / Q000150:complications / Q000473:pathology / Q000517:prevention & control; D008113:Liver Neoplasms / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D015337:Multicenter Studies as Topic; D012306:Risk
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D007372:Interferons